AIM Rule 26
Information required to be disclosed under Rule 26 of the AIM Rules for Companies.
AIM Rule 26
Information disclosed under AIM Rule 26
For all investor related queries, please contact investors@abingdonhealth.com
Current constitutional documents
Most recent admission document
Details of Any Other Exchanges or Trading Platforms
The Company’s ordinary shares are also traded on the OTCQB Venture Market in the United States, under the ticker symbol “ABDXF”.
Details of any Restrictions on the Transfer of Securities
There are no restrictions on the transfer of Abingdon Health securities
Whether the Company is subject to the UK City Code on Takeovers and Mergers
The company is subject to the UK City Code on Takeovers and Mergers
Country of Incorporation and Main Country of Operation
Abingdon Health was incorporated in England and Wales on 16 January 2008 (Registration No. 06475379) and is headquartered in York, UK, with an additional site in Doncaster.
Number of Securities in Issue
Issued share capital consists of 252,751,490 ordinary shares of 0.025p each as at 30 June 2026.
AIM securities not in public hands
In so far as the Company is aware, the percentage of AIM securities not in public hands is 43.2% as at 30 June 2026.
Significant Shareholders (3% or over)
As at 30 June 2026, the Company is aware of the following significant shareholders of the issued share capital of the Company:
| Shareholder | Ordinary Shares | Issued Share Capital (%) |
|---|---|---|
| Octopus Investments Limited | 44,606,013 | 17.65% |
| Canaccord Genuity Wealth Mgt | 42,270,469 | 16.72% |
| Enterprise Ventures (General Partner NPIF YHTV Equity) Ltd / Mercia | 18,071,164 | 7.15% |
| Rathbones Investment Mgt | 17,699,287 | 7.00% |
| Chris Hand | 13,678,467 | 5.41% |
This information was last updated on 28th July 2026.
AIM Rule 26
Advisors
Cavendish Capital Markets Limited
One Bartholomew Close
London
EC1A 7BL
Squire Patton Boggs (UK) LLP
6 Wellington Place
Leeds
LS1 4AP
RSM UK Audit LLP
Fifth Floor
Central Square
29 Wellington Street
Leeds
LS1 4DL
MUFG Corporate Markets
Central Square
29 Wellington St
Leeds
LS1 4DL
Need further information?
Contact the investor relations team for additional AIM Rule 26 disclosures or corporate governance enquiries.